Exploring the Effect of Fespixon Cream for the Treatment of Diabetic Foot Ulcers (TEXAS 3A, 3B)
Status:
Not yet recruiting
Trial end date:
2023-12-31
Target enrollment:
Participant gender:
Summary
A Research Study to evaluate the therapeutic effect of Fespixon cream in patients suffering
from DFU (UTWCS Grade III-A or III-B) by measuring the change of grade of UTWCS (University
of Texas Diabetic Wound Classification system), wound area reduction, infection control, and
incidence of treatment-emergent adverse event (TEAE).